Characterisation of Agonist-Receptor Interaction: Occupancy, Affinity, Dose-Response Curve, Potency, Efficacy Flashcards
Types of Receptor Ligands
Agonist
Full Agonist: can evoke maximal effect
Partial Agonist: evokes submaximal effect
Antagonist
Allosteric Modulator
Inverse Agonist
‘Equation’ of Agonist Action
Agonist + Free Receptor Agonist Receptor Complex
Agonist Receptor Complex –> Activated Agonist-R Comp.
Activated Agonist-R Complex–> Effect
Concentration- Occupancy Relationship
Agonist + Free Receptor Agonist Receptor Complex
Definition of Occupancy
Fraction or percentage of receptors occupied by agonist
Hill Langmuir Equation
p= Nl/Nt = c/ (c+(k2/k1)) = c/ (c+Kd)
p= Receptor occupancy Nl= # Ligand Bound Rs Nt= total # receptors
c= ligand conc k2= Rate constant for dissociation k1= Rate constant for association
Kd= equilibrium dissociation constant of agonist-R compl.
Ligand conc. causing 50% occupancy
Conclusions based on the Hill Langmuir Equation
Occupancy depends on
Ligand concentration and Kd
With high ligand concentrations occupancy approaches 1
Ergo: Ligand binding is saturable
Graphical form of Hill Langmuir Equation
Sigmoid shaped using log scale
(hyperbola in normal conc scale)
Y Axis: Occupancy (%)
X Axis: log Conc
Turning point of sigmoid shape: Kd: 50% occupancy
Kd
Characterises binding tendency of ligand–> affinity
Inversely proportional: Increase Kd, decrease affinity
High affinity-> high selectivity
Ligand binds to target R at low conc
Fewer SEs
EC50: Agonist conc. evoking 50%
Characterises potency of drug
Concentration- Response Curves
Full Agonists
Partial Agonist with IA=0.5
Antagonist
Full Agonists reach 100% Effect; full height sigmoid
Middle part near linear
Partial Agonist with IA=0.5 (can be between 0 and 1)
Only reaches 50% Effect; half sized sigmoid
Less steep–> larger margin of safety
Antagonist
Line at bottom; doesn’t reach any effect
Potency Rank:
A, B> C
C will require higher dose for still lower effect
Parameters of Concentration- Response Curve
Maximum of curve= efficacy
Expressed by IA
Clinical sig: determines how severe symp/ diseases
can be treated.
More severe–> need more efficacious drug
Position of curve along conc/dose axis: Potency Conc/dose req to induce given effect Drug needing lower conc is more potent EC 50 (conc) or ED50 (dose) Determines dosing: less potent-> higher conc needed
Slope of near-linear middle part of curve
Indicated how large increase of effect prod. by
increasing conc.
Related to margin of safety: steeper- smaller margin
Affinity
Potency
Efficacy
Intrinsic Activity
Affinity
Binding tendency of a ligand
Inversely proportional to Kd
Can only be compared when drugs bind same R
Potency
Conc. of dose req to induce given effect
Lower dose-> higher potency; characterised by ED50
Dep on affinity, signal amplification, R density, intrinsic
efficacy
Efficacy
Max of curve, max effect provoked by drug
Expressed by IA
Dep on intrinsic efficacy, signal amplification, R density
Intrinsic Activity
(Max Effect Inducible by drug) / (max effect possible in
given tissue)
Range 0-1
Receptor Reserve
Max effect that can be elicited with submaximal R occupancy: R reserve is fraction of Rs that are apparently not req for maximal effect
May be due to
High signal amplification during signal transduction
High R density
(High intrinsic efficacy of agonist)
Receptor downreg doesn’t decrease max. effect of full agonist (until certain limit)
Effect of R down-regulation on full agonist
Decrease in potency and efficacy
Sigmoid curve decreases in size and shifts to right (need higher concentration)
Intrinsic Efficacy
Describes receptor activating ability/ power of agonist
Describes how efficiently R occupancy translates into effect
Higher intrinsic efficacy-> increase efficacy until max possible effect of tissue reached
After: appearance and increase in receptor reserve
On curve:
Increased intrinsic efficacy-> shift to the left
Unlike IA: doesn’t have upper value: suitable to distinguish between R activating abilities of full agonists
Factors determining effect of an agonist
Number of activated Rs
Intrinsic efficacy
Agonist specific parameters
Agonist conc
Affinity (Kd)
Intrinsic efficacy
Tissue specific parameters
Receptor density
Signaling amplification